Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 31   

Articles published

PRAN 4.44 +0.09 (2.07%)
price chart
Prana Biotechnology Ltd. ADR
Prana Biotechnology Ltd. ADR. NASDAQ: PRAN. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
DOW JONES, A NEWS CORP COMPANY
Prana Biotechnology Ltd. ADR PRAN (U.S.: Nasdaq). search. View All companies. AT CLOSE 3:57 PM EDT 07/22/16. $4.39 USD; 0.04 0.92%. Volume 8,117. Volume 8,117. 65 Day Avg Vol 37,453. 1 Day Range 4.32 - 4.5228. 52 Week Range 2.70 - 7.38 ...
Why Prana Biotechnology Limited and Medbox Inc. Lost Big Today
Prana Biotechnology Limited (NASDAQ:PRAN) and Medbox Inc. (NASDAQOTH:MDBX) were the big losers in the health-care space today, and in this segment from Wednesday's Market Checkup, Motley Fool health-care analyst David Williamson looks at ...
Related articles »  
Down 70%: Is Prana Biotechnology Ltd. a Buy?
The biggest loser today in the biotech space was Prana Biotechnology (NASDAQ:PRAN), down a massive 70% because its candidate Alzheimer's drug PBT2 failed its phase 2 trial.
Why Prana Biotech's & Momenta Pharma's Stock Prices Fell Yesterday  Bidness Etc
Prana Biotech Plunges as Drug Fails in Alzheimer Study  Bloomberg
Related articles »  
Prana Biotechnology Limited Ads (NASDAQ:PRAN) Shorted Shares Increased By 66.78%
The short interest to Prana Biotechnology Limited Ads's float is 3.68%. The stock decreased 3.76% or $0.17 on July 21, hitting $4.35.
Prana: Right Drug, Wrong Dose
Prana Biotechnology Limited (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer's disease within the coming month.
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term ...
One company in particular, Prana Biotechnology (NASDAQ:PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN): The Research Programs Will Go On
Boston, MA, 04/09/2014 (usastockreport) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds.
Related articles »  
Ask a Fool: What's Your Foolish Take on Prana Biotechnology?
Any successful treatment to emerge for either of these indications would be a blockbuster, but real success has been extremely limited here, as these disorders are proving extremely difficult to crack. David cites an article from Summer Street today ...
Related articles »  
Five Stocks on the Move Today Amid a Mixed Market
Among individual stocks, Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Michael Kors Holdings Ltd (NYSE:KORS), Advanced Micro Devices, Inc. (NASDAQ:AMD), Marathon Oil Corporation (NYSE:MRO) and Cobalt International Energy, Inc.